FDA facing backlash over decision to halt us of two antibody treatments
ABC NEWS– Pfizer says it is testing an omicron-specific vaccine booster. This comes as the Food and Drug Administration faces backlash over its decision to halt the use of two antibody treatments.
ABC’s Reena Roy has the latest.